Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
The Journal of Organic Chemistry|February 12, 2005
tert-Buyldiphenylsilylethyl ("TBDPSE"): a practical protecting group for phenolsBrian S Gerstenberger, Joseph P KonopelskiOrganic Letters|April 24, 2009
One-pot synthesis of N-arylpyrazoles from arylhalidesBrian S Gerstenberger, Mark R Rauckhorst, Jeremy T StarrVirus Research|August 26, 2000
Rubella virus nonstructural protein 2 is a minor immunogenJ Hofmann, S Gerstenberger, I Lachmann, et al.Nature Microbiology|May 4, 2023
Therapeutics for COVID-19Sima S Toussi, Jennifer L Hammond, Brian S Gerstenberger, et al.Organic Letters|August 16, 2008
Diazonamide support studies: stereoselective formation of the C10 chiral center in both the CDEFG and AEFG fragmentsJinzhen Lin, Brian S Gerstenberger, Nhu Y T Stessman, et al.Organic Letters|November 9, 2002
Carbanion stabilization by distal silyloxy groups. Origin of the high diastereoselectivity in the formation of quaternary centers with aryllead(IV) triacetate reagentsJoseph P Konopelski, Jinzhen Lin, Philip J Wenzel, et al.Organic Letters|January 10, 2008
Structural characterization of an enantiomerically pure amino acid imidazolide and direct formation of the beta-lactam nucleus from an alpha-amino acidBrian S Gerstenberger, Jinzhen Lin, Yvette S Mimieux, et al.Organic Letters|November 5, 2016
Synthesis of Chiral Azabicycles from PyroglutaminolsChulho Choi, Philippe Nuhant, James J Mousseau, et al.Journal of Medicinal Chemistry|October 27, 2012
Covalent inhibitors of interleukin-2 inducible T cell kinase (itk) with nanomolar potency in a whole-blood assayChristoph W Zapf, Brian S Gerstenberger, Li Xing, et al.Scientific Reports|June 4, 2020
Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency DifferencesBrian S Gerstenberger, Mary Ellen Banker, James D Clark, et al.Pageof 3